These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11958832)

  • 41. Differential regulation of striatal G protein levels following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration in C57 BL/6 mice.
    Marcotte ER; Chugh A; Barlas C; Mishra RK
    Neurosci Lett; 2001 Jun; 306(1-2):21-4. PubMed ID: 11403948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of monoamine oxidase inhibitors on the diethyldithiocarbamate-induced enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in C57BL/6 mice.
    Takahata K; Shimazu S; Yoneda F; Ogawa M; Iida Y; Saji H
    J Neural Transm (Vienna); 2003 Aug; 110(8):859-69. PubMed ID: 12898342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of D-Ala
    Verma MK; Goel R; Nandakumar K; Nemmani KVS
    Eur J Pharmacol; 2017 Jun; 804():38-45. PubMed ID: 28366809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of nicotine on 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced depression of striatal dopamine content and spontaneous locomotor activity in C57 black mice.
    Gao ZG; Cui WY; Zhang HT; Liu CG
    Pharmacol Res; 1998 Aug; 38(2):101-6. PubMed ID: 9721596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amiloride is neuroprotective in an MPTP model of Parkinson's disease.
    Arias RL; Sung ML; Vasylyev D; Zhang MY; Albinson K; Kubek K; Kagan N; Beyer C; Lin Q; Dwyer JM; Zaleska MM; Bowlby MR; Dunlop J; Monaghan M
    Neurobiol Dis; 2008 Sep; 31(3):334-41. PubMed ID: 18606547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice.
    Boeckler F; Leng A; Mura A; Bettinetti L; Feldon J; Gmeiner P; Ferger B
    Biochem Pharmacol; 2003 Sep; 66(6):1025-32. PubMed ID: 12963489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
    J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenosine A1 and A2A receptors are not upstream of caffeine's dopamine D2 receptor-dependent aversive effects and dopamine-independent rewarding effects.
    Sturgess JE; Ting-A-Kee RA; Podbielski D; Sellings LH; Chen JF; van der Kooy D
    Eur J Neurosci; 2010 Jul; 32(1):143-54. PubMed ID: 20576036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice.
    Parain K; Marchand V; Dumery B; Hirsch E
    Brain Res; 2001 Feb; 890(2):347-50. PubMed ID: 11164803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor necrosis factor-alpha receptor ablation in a chronic MPTP mouse model of Parkinson's disease.
    Leng A; Mura A; Feldon J; Ferger B
    Neurosci Lett; 2005 Feb; 375(2):107-11. PubMed ID: 15670651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism.
    Singh K; Singh S; Singhal NK; Sharma A; Parmar D; Singh MP
    Chem Biol Interact; 2010 Apr; 185(2):81-93. PubMed ID: 20230807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential neuroprotective effect of low dose whole-body gamma-irradiation against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice.
    Liang Y; Li S; Zou Q; Su B
    Neurosci Lett; 2006 Jun; 400(3):213-7. PubMed ID: 16540245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene.
    Boger HA; Middaugh LD; Zaman V; Hoffer B; Granholm AC
    Brain Res; 2008 Nov; 1241():18-28. PubMed ID: 18822276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro.
    Genc S; Akhisaroglu M; Kuralay F; Genc K
    Neurosci Lett; 2002 Mar; 321(1-2):73-6. PubMed ID: 11872260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice.
    Mitsumoto Y; Mori A; Ohashi S; Nakai M; Moriizumi T
    Neurosci Res; 2005 Jan; 51(1):111-5. PubMed ID: 15596247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO
    Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
    J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice.
    Quik M; Sum JD; Whiteaker P; McCallum SE; Marks MJ; Musachio J; McIntosh JM; Collins AC; Grady SR
    Mol Pharmacol; 2003 May; 63(5):1169-79. PubMed ID: 12695545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.